Patients receiving stem cell–derived pancreatic islet cell infusions have produced their own insulin without daily injections in early-phase results, the most-watched readout in regenerative medicine this year — and the clearest signal yet that replacement cell therapy is crossing from promise into practice.
Gene-edited 'universal donor' cell lines survived without immunosuppression in new preclinical data, a step toward off-the-shelf cell therapies. Early work — human safety data still ahead.
Read summary →The field's flagship journal proposes new reporting standards for induced pluripotent stem cell lines entering trials — a move regulators are watching closely.
Read summary →Three mid-stage stem cell trials report in the next 90 days. Here's what the endpoints are, and how to read the results when they land.
Read summary →From orthopedic repair to immune modulation, MSCs appear in more registered trials than any other adult stem cell. We mapped where the evidence is strong, emerging, and absent.
Read summary →New manufacturing and characterization standards are giving exosome research a reproducibility backbone it has lacked for a decade.
Read summary →FDA's cellular and gene therapy database distinguishes approved products from investigational ones. We walk through the exact check patients and journalists should run before believing a clinic's claim.
Read summary →The International Society for Stem Cell Research publishes the field's definitive patient guide. Six red flags, and the questions that expose them.
Read summary →The field's most closely followed independent analyst on why enforcement, registries, and honest journalism are winning — and what's still at stake.
Read summary →California's regenerative medicine institute argues the quiet part out loud: the unglamorous trials that change medicine get funded by agencies, not pitch decks.
Read summary →Your body already runs a stem cell system — cells released from bone marrow that circulate to tissues needing routine maintenance. Stemtech, the company that pioneered this category, formulates nutritional supplements designed to support that natural system: release, circulation, migration.
A botanical blend formulated to support the body's natural release of adult stem cells from bone marrow into circulation — the first link in the chain.
Explore at Stemtech →Formulated to support healthy blood flow — helping circulating stem cells reach the capillary networks where they're needed most.
Explore at Stemtech →Designed to support the natural migration signals that guide circulating stem cells to tissues calling for routine maintenance and renewal.
Explore at Stemtech →These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Stemtech products are dietary supplements. Stem Cell Wire is an independently edited news digest presented by Stemtech Corporation; sponsor support is disclosed on every page.
Talk with our AI nutrition guide about your wellness goals, energy, mobility, healthy aging — and how the science of stem cell nutrition fits your daily routine. No pressure, no obligation: just clear, personal guidance.
Consultation is educational only and is not medical advice. Stemtech products are dietary supplements, not intended to diagnose, treat, cure, or prevent any disease.
Stem cells are the body's raw materials — undifferentiated cells that can develop into many cell types and act as an internal repair system. Adult stem cells naturally circulate from bone marrow to tissues needing maintenance.
Start with ClinicalTrials.gov (US NIH) and the WHO ICTRP. A legitimate trial is FDA- or health-ministry-approved Phase I–III research — never a paid observational registration marketed as treatment.
Per ISSCR guidance: one cell type claimed to treat many unrelated conditions, no regulatory approval or IND status, testimonials in place of trial data, and large upfront fees for "experimental" care. Verify any claim against the FDA database before paying anyone.
A supplement category formulated to support the body's natural release and circulation of adult stem cells. Stemtech Corporation pioneered the category. These are supplements, not drugs — and no supplement treats disease.